Melanoma

News
FDA Approves Atezolizumab Combo for BRAF V600+ Melanoma
08/03/2020
The FDA has approved atezolizumab plus cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive unresectable or metastatic melanoma.
The FDA has approved atezolizumab plus cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive unresectable or metastatic melanoma.
The FDA has approved...
08/03/2020
Oncology
News
Advances in RT Lead to Improved Outcomes in Patients With Melanoma Brain Metastases
07/30/2020
The evolution of RT techniques and therapies for melanoma brain metastases have improved outcomes among patients since 2007, according to a population-based study.
The evolution of RT techniques and therapies for melanoma brain metastases have improved outcomes among patients since 2007, according to a population-based study.
The evolution of RT techniques...
07/30/2020
Oncology
Measuring Immune Checkpoint Inhibition Efficacy via Treatment-Free Survival in Advanced Melanoma
Commentary
Measuring Immune Checkpoint Inhibition Efficacy via Treatment-Free Survival in Advanced Melanoma
04/20/2020
Experts are developing a novel clinical trial outcome measure to characterize the antitumor activity of ICI protocol therapy in advanced melanoma.
Experts are developing a novel clinical trial outcome measure to characterize the antitumor activity of ICI protocol therapy in advanced melanoma.
Experts are developing a novel...
04/20/2020
Oncology
News
Immune Checkpoint Inhibitor Type, Dose Influence Risk for AEs in Melanoma
04/09/2020
A review of randomized trials in patients with advanced melanoma showed that the risk for immune-related AEs varies based on immune checkpoint inhibitor type and dose.
A review of randomized trials in patients with advanced melanoma showed that the risk for immune-related AEs varies based on immune checkpoint inhibitor type and dose.
A review of randomized trials in...
04/09/2020
Oncology
News
Nomogram Could Help Select Patients With Melanoma to Undergo Biopsies
04/01/2020
Researchers propose using an externally validated nomogram to better select patients with T1 melanoma to undergo sentinel node biopsy.
Researchers propose using an externally validated nomogram to better select patients with T1 melanoma to undergo sentinel node biopsy.
Researchers propose using an...
04/01/2020
Oncology
News
Study Findings Stress Importance of Primary Tumor Mitotic Rate in Melanoma
02/10/2020
Study findings highlight the importance of the primary tumor mitotic rate, and provide a framework for evidence-based surveillance of CNS metastasis in stage III melanoma.
Study findings highlight the importance of the primary tumor mitotic rate, and provide a framework for evidence-based surveillance of CNS metastasis in stage III melanoma.
Study findings highlight the...
02/10/2020
Oncology
Interview
Monitoring Ipilimumab Response in Patients with Metastatic Melanoma
05/07/2019
Wolfgang Weber, MD, discusses the link between tumor response on 18F-FDG PET/CT and prognosis in patients treated with ipilimumab.
Wolfgang Weber, MD, discusses the link between tumor response on 18F-FDG PET/CT and prognosis in patients treated with ipilimumab.
Wolfgang Weber, MD, discusses...
05/07/2019
Oncology

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use